Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08646 | 32033764 | Gastroenterol Clin North Am | How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis. | 2019 | Details |
| A08647 | 32033763 | Gastroenterol Clin North Am | Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08648 | 32033762 | Gastroenterol Clin North Am | Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant. | 2020 | Details |
| A08649 | 32033761 | Gastroenterol Clin North Am | Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis. | 2019 | Details |
| A08650 | 32033760 | Gastroenterol Clin North Am | Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08651 | 32033759 | Gastroenterol Clin North Am | Recruitment and Retention of Patients for Nonalcoholic Steatohepatitis Clinical Trials. | 2020 | Details |
| A08652 | 32033758 | Gastroenterol Clin North Am | Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08653 | 32033757 | Gastroenterol Clin North Am | Burden of Disease due to Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08654 | 32033223 | Nutrients | Beneficial Effects of a Low-dose of Conjugated Linoleic Acid on Body Weight Gain and other Cardiometabolic Risk Factors in Cafeteria Diet-fed Rats. | 2020 | Details |
| A08655 | 32031871 | Am J Physiol Heart Circ Physiol | Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. | 2020 | Details |
| A08656 | 32031683 | Hepatology | Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis. | 2020 | Details |
| A08657 | 32030821 | J Gastroenterol Hepatol | Aging exacerbates high-fat diet-induced steatohepatitis through alteration in hepatic lipid metabolism in mice. | 2020 | Details |
| A08658 | 32029710 | Cell Death Dis | Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease. | 2020 | Details |
| A08659 | 32029622 | Science | An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. | 2020 | Details |
| A08661 | 32029456 | Genes Dev | The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism. | 2020 | Details |
| A08662 | 32029233 | Mol Metab | Hepatic ERα accounts for sex differences in the ability to cope with an excess of dietary lipids. | 2019 | Details |
| A08663 | 32029220 | Mol Metab | Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. | 2019 | Details |
| A08664 | 32028646 | Medicina (Kaunas) | 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease. | 2020 | Details |
| A08665 | 32028458 | Med Sci Sports Exerc | Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD. | 2020 | Details |
| A08666 | 32028242 | Int Immunopharmacol | Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis. | 2020 | Details |
| A08667 | 32027911 | Gastroenterology | Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A08669 | 32027858 | Lancet Gastroenterol Hepatol | FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. | 2020 | Details |
| A08670 | 32027419 | J Gastroenterol Hepatol | Effects of constant light exposure on sphingolipidomics and progression of NASH in high-fat-fed rats. | 2020 | Details |
| A08671 | 32027126 | J Chem Inf Model | Discovery of Novel Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists by Virtual Screening and Biological Evaluation. | 2020 | Details |
| A08672 | 32026851 | Med Sci Monit | The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid. | 2020 | Details |
| A08674 | 32025604 | Hepatol Commun | Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery. | 2019 | Details |
| A08675 | 32025251 | J Med Life | Cellular Interactions in the Human Fatty Liver. | 2020 | Details |
| A08676 | 32025168 | J Clin Exp Hepatol | NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet? | 2019 | Details |
| A08677 | 32025167 | J Clin Exp Hepatol | Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. | 2019 | Details |
| A08678 | 32025166 | J Clin Exp Hepatol | 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. | 2019 | Details |
| A08679 | 32025164 | J Clin Exp Hepatol | Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965. | 2019 | Details |
| A08680 | 32024826 | Nat Commun | Liver governs adipose remodelling via extracellular vesicles in response to lipid overload. | 2020 | Details |
| A08681 | 32024509 | BMC Complement Med Ther | Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats. | 2020 | Details |
| A08682 | 32023709 | Zhonghua Gan Zang Bing Za Zhi | [Value of detection of extracellular vesicles in the diagnosis of nonalcoholic fatty liver disease]. | 2020 | Details |
| A08683 | 32023702 | Zhonghua Gan Zang Bing Za Zhi | [Effect of metformin on mitochondrial pathway of apoptosis and oxidative stress in cell model of nonalcoholic fatty liver disease]. | 2020 | Details |
| A08684 | 32023549 | Aging (Albany NY) | Targeting of miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr-/- mice via p66shc/cytochrome C cascade. | 2020 | Details |
| A08685 | 32022950 | J Eur Acad Dermatol Venereol | The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. | 2020 | Details |
| A08686 | 32022277 | Hepatology | Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. | 2020 | Details |
| A08687 | 32021375 | J Inflamm Res | Saturated Fatty Acids in Obesity-Associated Inflammation. | 2020 | Details |
| A08688 | 32020961 | Med J Armed Forces India | The good, the bad, and the ugly facets of insulin resistance. | 2020 | Details |
| A08689 | 32020874 | BMC Complement Med Ther | Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats. | 2020 | Details |
| A08690 | 32020788 | Wiley Interdiscip Rev Syst Biol Med | Liver gene regulatory networks: Contributing factors to nonalcoholic fatty liver disease. | 2020 | Details |
| A08691 | 32020770 | Pediatr Obes | Effect of the patatin-like phospholipase domain containing 3 gene (PNPLA3) I148M polymorphism on the risk and severity of nonalcoholic fatty liver disease and metabolic syndromes: A meta-analysis of paediatric and adolescent individuals. | 2020 | Details |
| A08692 | 32020523 | Biol Trace Elem Res | The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial. | 2020 | Details |
| A08693 | 32020371 | Curr Atheroscler Rep | Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis. | 2020 | Details |
| A08694 | 32020359 | Dig Dis Sci | Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction. | 2020 | Details |
| A08695 | 32019846 | Occup Environ Med | Rotating night shift work and non-alcoholic fatty liver disease among steelworkers in China: a cross-sectional survey. | 2020 | Details |
| A08696 | 32019793 | mBio | Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08697 | 32019572 | J Med Case Rep | Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report. | 2020 | Details |
| A08698 | 32019569 | Lipids Health Dis | The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study. | 2020 | Details |
| A08699 | 32019315 | Rev Esp Enferm Dig | Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma. | 2020 | Details |
| A08700 | 32018285 | Dtsch Med Wochenschr | [Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies]. | 2020 | Details |
| A08701 | 32017891 | Am J Med | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? | 2020 | Details |
| A08702 | 32017849 | J Med Chem | [1,2,5]Oxadiazolo[3,4-b]pyrazine-5,6-diamine Derivatives as Mitochondrial Uncouplers for the Potential Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08703 | 32017594 | Am J Physiol Endocrinol Metab | Combined effect of canagliflozin and exercise training on high-fat diet-fed mice. | 2020 | Details |
| A08704 | 32017389 | Diabetes Metab Res Rev | Lower eGFR is associated with increased probability of liver fibrosis in Chinese diabetic patients. | 2020 | Details |
| A08705 | 32017151 | J Food Biochem | Curcuma longa and Trigonella foenum graecum-enriched nutrient mixture from germinated Macrotyloma uniflorum and Vigna radiate ameliorate nonalcoholic fatty liver diseases in rats. | 2020 | Details |
| A08706 | 32017057 | Eur J Clin Invest | Systemic redox imbalance in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08707 | 32016853 | Pharmacol Rep | New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. | 2020 | Details |
| A08708 | 32016448 | Mol Med Rep | Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling. | 2020 | Details |
| A08710 | 32015930 | Liver Res | The acidic pathway of bile acid synthesis: Not just an alternative pathway☆. | 2019 | Details |
| A08711 | 32015483 | Sci Rep | Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model. | 2020 | Details |
| A08712 | 32015322 | Cell Death Dis | Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis. | 2020 | Details |
| A08713 | 32014594 | Int J Surg | Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research. | 2020 | Details |
| A08714 | 32013841 | Curr Pharm Des | Lifestyle Changes for the Treatment of Nonalcoholic Fatty Liver Disease - A 2015-19 Update. | 2020 | Details |
| A08715 | 32013792 | Radiology | Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US. | 2020 | Details |
| A08716 | 32012908 | Cells | Unraveling LMNA Mutations in Metabolic Syndrome: Cellular Phenotype and Clinical Pitfalls. | 2020 | Details |
| A08717 | 32012320 | Hepatology | Epidemiological Features of NAFLD From 1999 to 2018 in China. | 2020 | Details |
| A08718 | 32012316 | Hepatology | Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08719 | 32012315 | Biomed Chromatogr | Systematic investigation on the chemical basis of anti-NAFLD Qushi Huayu Fang. Part 1: A study of metabolic profiles in vivo and in vitro by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. | 2020 | Details |
| A08721 | 32011470 | Medicine (Baltimore) | Acupoint embedding therapy improves nonalcoholic fatty liver disease with abnormal transaminase: A PRISMA-compliant systematic review and meta-analysis. | 2020 | Details |
| A08725 | 32010935 | Biosci Rep | Letter to the Editor: Comments on "Obesity associated with a novel mitochondrial tRNACys m.5802A>G mutation in a Chinese family". | 2020 | Details |
| A08726 | 32010600 | J Transl Int Med | Role of Hepatokines in Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A08727 | 32010250 | Exp Ther Med | Integrated microRNA and proteome analysis reveal a regulatory module in hepatic lipid metabolism disorders in mice with subclinical hypothyroidism. | 2019 | Details |
| A08728 | 32009609 | Turk J Gastroenterol | Inborn errors of metabolism in the differential diagnosis of fatty liver disease. | 2020 | Details |
| A08729 | 32008345 | Orv Hetil | [Effects of physical activity in nonalcoholic fatty liver disease]. | 2020 | Details |
| A08730 | 32008226 | Aging Clin Exp Res | Prognostic value of non-alcoholic fatty liver disease in the elderly patients. | 2020 | Details |
| A08731 | 32008185 | J Endocrinol Invest | Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD. | 2020 | Details |
| A08732 | 32007822 | J Nutr Biochem | Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis. | 2019 | Details |
| A08733 | 32007744 | Prostaglandins Leukot Essent Fatty Acids | Iron-induced derangement in hepatic Δ-5 and Δ-6 desaturation capacity and fatty acid profile leading to steatosis: Impact on extrahepatic tissues and prevention by antioxidant-rich extra virgin olive oil. | 2020 | Details |
| A08734 | 32007335 | Nutr Metab Cardiovasc Dis | Addition of fish oil to atherogenic high fat diet inhibited atherogenesis while olive oil did not, in LDL receptor KO mice. | 2019 | Details |
| A08735 | 32006558 | Metabolism | Complications, morbidity and mortality of nonalcoholic fatty liver disease. | 2020 | Details |
| A08736 | 32006545 | Gastroenterology | AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A08737 | 32006266 | Adv Exp Med Biol | Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors. | 2021 | Details |
| A08738 | 32005637 | Ann Hepatol | Osteopontin - A potential biomarker of advanced liver disease. | 2020 | Details |
| A08739 | 32005510 | Ultrasound Med Biol | Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08740 | 32005283 | Trials | Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. | 2020 | Details |
| A08741 | 32004929 | J Nutr Biochem | Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet. | 2020 | Details |
| A08742 | 32003680 | Curr Pharm Des | Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities? | 2020 | Details |
| A08743 | 32003679 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State? | 2020 | Details |
| A08744 | 32003662 | Curr Pharm Des | Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). | 2020 | Details |
| A08745 | 32003601 | Am J Physiol Gastrointest Liver Physiol | Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. | 2020 | Details |
| A08746 | 32002742 | Sleep Breath | Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08747 | 32002713 | Inflammation | Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD. | 2020 | Details |
| A08748 | 32001554 | Gut | Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. | 2020 | Details |
| A08749 | 32001430 | Wiad Lek | Correction of adipocyte secretion disorders in patients with non-alcoholic fatty liver disease with overweight and obesity | 2019 | Details |
| A08750 | 32001302 | Microb Pathog | Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis. | 2020 | Details |
| A08751 | 32001301 | Biochim Biophys Acta Mol Basis Dis | Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver. | 2020 | Details |
| A08752 | 32000955 | J Am Coll Cardiol | Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. | 2020 | Details |
| A08753 | 32000639 | Curr Pharm Des | Dysmetabolic Iron Overload in Metabolic Syndrome. | 2020 | Details |